|
Donald J. Treacy Ph.D. has served as our vice president analytical sciences since January 2004. Dr. Treacy joined us as director analytical research and development in March 2000. Dr. Treacy has 13 years of industry experience including 12 years in drug development and novel drug delivery systems.
From 1993 to 2000 Dr. Treacy was employed at Shire Laboratories Inc./Pharmavene. While at Shire Laboratories he held management positions with increasing responsibilities in analytical method development validation clinical trial material release and NDA stability. Prior to that Dr. Treacy performed analytical method development and photodegradation research at the National Cancer Institute. Dr. Treacy has a bachelor?s degree from Roanoke College and received a Ph.D. in analytical chemistry from the University of Maryland. | 